BVCF (BioVeda China Fund), a Shanghai-based private equity and venture investment firm focused on life sciences, is targeting US$400 million for its fourth U.S. dollar... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals